Spyre Therapeutics (SYRE) Price to Sales (2017 - 2024)
Spyre Therapeutics' Price to Sales was 2019.42 in Q1 2024, up 244.3% from 586.61 a year earlier.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Price to Sales (2017 - 2024) Analysis & Trends
For FY2023, Price to Sales at Spyre Therapeutics came in at 178.29, down 56.2% from FY2022.
- In earlier years, Price to Sales was 407.11 in FY2022 (-2.3%) and 416.63 in FY2021.
- The Q1 2024 figure marks the highest quarterly Price to Sales since Q1 2019.
- Compared with a year earlier, Price to Sales was higher in three of the last eight quarters, with growth averaging 71.3%.
- The best year-over-year quarter for Price to Sales over five years was Q2 2023 (growth of 403.7%); the worst was Q2 2022 (a decline of 82.3%).
- Per Business Quant data, SYRE's Price to Sales in the three quarters before Q1 2024 was 178.29 (Q4 2023), 59.02 (Q3 2023) and 743.40 (Q2 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Spyre Therapeutics | 9.40 Bn | 5.68 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | 2,019.42 |
| Dec 31, 2023 | 178.29 |
| Sep 30, 2023 | 59.02 |
| Jun 30, 2023 | 29.74 |
| Mar 31, 2023 | 23.46 |
| Dec 31, 2022 | 16.28 |
| Sep 30, 2022 | 8.54 |
| Jun 30, 2022 | 5.90 |
| Mar 31, 2022 | 7.55 |
| Dec 31, 2021 | 16.67 |
| Sep 30, 2021 | 34.65 |
| Jun 30, 2021 | 33.35 |
| Mar 31, 2019 | 97.62 |
| Dec 31, 2018 | 46.50 |
| Sep 30, 2018 | 39.37 |
| Jun 30, 2018 | 34.95 |
| Mar 31, 2018 | 29.09 |
| Dec 31, 2017 | 17.33 |
API Access
Spyre Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();